NCT01711424已完成不适用
An Observational Study of OPTIVE PLUS® for the Treatment of Dry Eye Disease
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Allergan
- 入组人数
- 1,209
- 主要终点
- Number of Participants Very Satisfied or Satisfied With OPTIVE PLUS®
研究概览
简要总结
This is an observational study of OPTIVE PLUS® in patients with dry eye disease in a routine clinical setting. Treatment decisions are made by the physician and reflect the physician's current standard of care.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of dry eye
- •Physician decision to treat with OPTIVE PLUS® in accordance with the physician's standard practice
排除标准
- 未提供
研究组 & 干预措施
OPTIVE PLUS®
Patients with dry eye prescribed OPTIVE PLUS® in accordance with physician standard practice.
干预措施: OPTIVE PLUS® (Drug)
结局指标
主要结局
Number of Participants Very Satisfied or Satisfied With OPTIVE PLUS®
时间窗: Week 4
Patients rated their satisfaction with OPTIVE PLUS® as treatment for dry eye signs and symptoms using a 4-point scale (Very satisfied, Satisfied, Dissatisfied or Very dissatisfied).
次要结局
- Number of Participants Where Physician Was Very Satisfied or Satisfied With OPTIVE PLUS®(Week 4)
- Tear Break Up Time (TBUT)(Baseline, Week 4)
- Schirmer Score(Baseline, Week 4)
研究者
相似试验
招募中
不适用
Observational Study on the Improvement of Dry Eye Syndrome, Treatment Satisfaction, and Intraocular Tolerance With Diquasol Eye DropsDry Eye SyndromeNCT06172530Hanlim Pharm. Co., Ltd.2,000
已完成
不适用
Cross-linked CMC and Silk Proteins in Eye DiseaseDry Eye Disease (DED)NCT06605365D&V FARMA srl20
已完成
1 期
Study of ST266 Eye Drops in Treating Dry EyeDry Eye SyndromeNCT02369861Noveome Biotherapeutics, formerly Stemnion30
已完成
不适用
Clinical Trial to Assess the Effectiveness of I+Med's DayDrop Advanced Ophthalmic DropDry Eye SyndromeNCT06732830i+Med S.Coop.45
已完成
不适用
Dry Eye Symptom Mitigation by Oral Intake of ProbioticsDry EyeNCT05906381Chung Shan Medical University88